                         SEQUENCE LISTING

<110>  Viracine Therapeutics Corporation
 
<120>  Compositions and Methods for Screening Antiviral Agents

<130>  VTC0003-00WO

<150>  61/583493
<151>  2012-01-05

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  41
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer

<400>  1
ggccgtcatg gtggcgaata agtctagcca tggcgttagt a                           41


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer

<400>  2
ctcccggggc actcgcaagc                                                   20


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer

<400>  3
agagccatag tggtctgcgg                                                   20


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer

<400>  4
ctttcgcgac ccaacactac                                                   20


